A review of the economics of adult congenital heart disease

Michael D. Seckeler; Ian D. Thomas; Jennifer Andrews; Keith Joiner; Scott E. Klewer

doi:10.1586/14737167.2016.1140575

A review of the economics of adult congenital heart disease

Michael D. Seckeler, Ian D. Thomas, Jennifer Andrews, Keith Joiner, Scott E. Klewer

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

Adults living with congenital heart disease (CHD) now outnumber children with the disease. Thanks to medical advances over the past 75 years, many of these fatal childhood heart problems have changed to chronic medical conditions. As the population of adults with CHD increases, they will require increasingly complex medical, surgical and catheter-based therapies. In addition, social burdens including education, employment and insurability, which increase the societal costs of adult CHD, are now being recognized for adults living with CHD. This review summarizes the available literature on the economics of adult CHD.

Original language	English (US)
Pages (from-to)	85-96
Number of pages	12
Journal	Expert Review of Pharmacoeconomics and Outcomes Research
Volume	16
Issue number	1
DOIs	https://doi.org/10.1586/14737167.2016.1140575
State	Published - Jan 2 2016

Keywords

Adult congenital heart disease
Hypoplastic left heart syndrome
atrial septal defects
chronic disease
economics
healthcare resource utilization
tetralogy of Fallot

ASJC Scopus subject areas

Health Policy
Pharmacology (medical)

Access to Document

10.1586/14737167.2016.1140575

Cite this

@article{e97a29217b304b13b8dcefcc16d9fbd4,

title = "A review of the economics of adult congenital heart disease",

abstract = "Adults living with congenital heart disease (CHD) now outnumber children with the disease. Thanks to medical advances over the past 75 years, many of these fatal childhood heart problems have changed to chronic medical conditions. As the population of adults with CHD increases, they will require increasingly complex medical, surgical and catheter-based therapies. In addition, social burdens including education, employment and insurability, which increase the societal costs of adult CHD, are now being recognized for adults living with CHD. This review summarizes the available literature on the economics of adult CHD.",

keywords = "Adult congenital heart disease, Hypoplastic left heart syndrome, atrial septal defects, chronic disease, economics, healthcare resource utilization, tetralogy of Fallot",

author = "Seckeler, {Michael D.} and Thomas, {Ian D.} and Jennifer Andrews and Keith Joiner and Klewer, {Scott E.}",

note = "Publisher Copyright: {\textcopyright} 2016 Taylor & Francis.",

year = "2016",

month = jan,

day = "2",

doi = "10.1586/14737167.2016.1140575",

language = "English (US)",

volume = "16",

pages = "85--96",

journal = "Expert Review of Pharmacoeconomics and Outcomes Research",

issn = "1473-7167",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - A review of the economics of adult congenital heart disease

AU - Seckeler, Michael D.

AU - Thomas, Ian D.

AU - Andrews, Jennifer

AU - Joiner, Keith

AU - Klewer, Scott E.

PY - 2016/1/2

Y1 - 2016/1/2

N2 - Adults living with congenital heart disease (CHD) now outnumber children with the disease. Thanks to medical advances over the past 75 years, many of these fatal childhood heart problems have changed to chronic medical conditions. As the population of adults with CHD increases, they will require increasingly complex medical, surgical and catheter-based therapies. In addition, social burdens including education, employment and insurability, which increase the societal costs of adult CHD, are now being recognized for adults living with CHD. This review summarizes the available literature on the economics of adult CHD.

AB - Adults living with congenital heart disease (CHD) now outnumber children with the disease. Thanks to medical advances over the past 75 years, many of these fatal childhood heart problems have changed to chronic medical conditions. As the population of adults with CHD increases, they will require increasingly complex medical, surgical and catheter-based therapies. In addition, social burdens including education, employment and insurability, which increase the societal costs of adult CHD, are now being recognized for adults living with CHD. This review summarizes the available literature on the economics of adult CHD.

KW - Adult congenital heart disease

KW - Hypoplastic left heart syndrome

KW - atrial septal defects

KW - chronic disease

KW - economics

KW - healthcare resource utilization

KW - tetralogy of Fallot

UR - http://www.scopus.com/inward/record.url?scp=84958166029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958166029&partnerID=8YFLogxK

U2 - 10.1586/14737167.2016.1140575

DO - 10.1586/14737167.2016.1140575

M3 - Review article

C2 - 26765559

AN - SCOPUS:84958166029

SN - 1473-7167

VL - 16

SP - 85

EP - 96

JO - Expert Review of Pharmacoeconomics and Outcomes Research

JF - Expert Review of Pharmacoeconomics and Outcomes Research

IS - 1

ER -

A review of the economics of adult congenital heart disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this